Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases susceptible to CIP,% cases susceptible to TET,% cases susceptible to CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"22,335 (8,213, 34,154)","60.3% (46.4%, 88.8%)","70.8% (55.3%, 83.1%)","17.2% (11.2%, 36.4%)","57.9% (44.4%, 86.7%)","21.1 (16.3, 31.1)","24.8 (19.4, 29.1)","6.0 (3.9, 12.7)","20.3 (15.5, 30.3)",,,,,
"(p=None, None), q=(None, None), c=0.500)","19,498 (7,459, 31,451)","68.9% (52.7%, 96.2%)","46.9% (29.7%, 71.6%)","9.6% (6.0%, 14.3%)","66.5% (50.2%, 95.1%)","24.1 (18.4, 33.7)","16.4 (10.4, 25.1)","3.4 (2.1, 5.0)","23.3 (17.6, 33.3)","-13.4% (-26.1%, -1.4%)","14.5% (5.5%, 23.3%)","-33.8% (-54.3%, -11.3%)","-38.2% (-71.3%, -4.1%)","14.9% (6.0%, 23.5%)"
"(p=None, None), q=(None, None), c=0.750)","19,760 (8,166, 32,861)","68.7% (52.0%, 94.7%)","45.6% (29.3%, 66.8%)","9.1% (5.5%, 12.9%)","66.4% (49.7%, 93.3%)","24.1 (18.2, 33.1)","15.9 (10.2, 23.4)","3.2 (1.9, 4.5)","23.2 (17.4, 32.6)","-11.6% (-23.4%, 0.4%)","14.3% (4.7%, 22.1%)","-35.7% (-55.8%, -17.0%)","-41.6% (-71.8%, -12.8%)","14.9% (4.9%, 22.9%)"
"(p=None, None), q=(None, None), c=1.000)","19,755 (8,199, 31,726)","69.6% (53.5%, 96.5%)","45.3% (28.5%, 69.1%)","8.7% (5.4%, 12.8%)","67.3% (51.1%, 95.6%)","24.4 (18.7, 33.8)","15.9 (10.0, 24.2)","3.1 (1.9, 4.5)","23.6 (17.9, 33.4)","-11.3% (-25.9%, 4.2%)","15.8% (7.3%, 24.6%)","-36.1% (-56.6%, -15.1%)","-43.9% (-73.6%, -14.6%)","16.5% (7.9%, 25.8%)"
